Co-founder, Crimson Biopharm
Jean Zhao is Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Dana-Farber Cancer Institute (DFCI). Her research centers on understanding signaling pathways in tumor and tumor immune environments. Her laboratory has pioneered a new front for understanding signal transduction by integrating mouse genetics, chemical biology and immunology to facilitate translational cancer research. Prof. Zhao’s productive and insightful work has not only addressed important basic science questions; it has also guided the design of current clinical trials integrating immunotherapy and targeted therapy at multiple cancer centers. Prof. Zhao has been widely recognized for her innovation and excellence in the field. Her honors and awards include the V Scholar Award, the Starr Foundation Award, the Outstanding Investigator Award from NIH/NCI, and the Breakthrough Award from DoD. She serves as a member on multiple scientific boards and committees, including the Executive Committee for Research and Clinical Science, the Committee for Women Faculty at DFCI, the Steering Committee of Breast Cancer at Dana-Farber/Harvard Cancer Center and the Advisory Council of the National Brain Tumor Society.